Although hyaluronic acid filler use predominates in aesthetic medicine, semipermanent fillers for softtissue augmentation have been available for more than 20 years. Delayed-onset nodules from injected polymethylmethacrylate (PMMA) dermal fillers… Click to show full abstract
Although hyaluronic acid filler use predominates in aesthetic medicine, semipermanent fillers for softtissue augmentation have been available for more than 20 years. Delayed-onset nodules from injected polymethylmethacrylate (PMMA) dermal fillers present as subcutaneous nodules that may develop months to years after the initial procedure. This complication may occur in up to 2% of patients having received PMMA containing dermal fillers. Foreign body reactions, biofilm, and inflammation are thought to play a role in nodule development, and therefore several treatments including antibiotics, intralesional triamcinolone/5-fluorouracil, or systemic corticosteroids have been used. Herein, we report clinical findings on 7 patients who presented with refractory delayed-onset nodules related to PMMA fillers and were treated with a long-pulsed 1,064-nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser.
               
Click one of the above tabs to view related content.